‘Keytruda SC’ FDA Approval…Obesity Drug Battle in Europe[Monthly K-bio Pulse] 김새미 2025.08.27 오전 10:30 K-Bio Stocks Fall as Tariff Concerns Offset Political Clarity[K-Bio Pulse] 나은경 2025.04.07 오전 07:49 Biodefense Bill, Abortion Pill Push Boost Market; Genomictree Climbs[K-Bio Pulse] 나은경 2025.08.13 오전 08:32 Celltrion Mulls U.S. Plant to Counter Expected Tariffs 송영두 2025.05.07 오전 09:22 Huons sees limited impact on its exports from Trump’s executive order aiming at lowering drug pr... 신민준 2025.05.14 오전 09:19 Samsung Biologics Sets Q1 Sales Record...Eyes KRW 5T Year 김승권 2025.04.23 오후 04:50 Trump Eyes Drug Tariffs-What It Means for K-Bio 김진수 2025.05.07 오전 10:16 Celltrion, Track to Achieve 5 Trillion won in Annual Revenue This Year with Successful U.S. Expan... 신민준 2025.03.06 오전 10:10 Celltrion Sees Opportunity in Trump Drug Pricing Order 김승권 2025.05.13 오후 03:16 Trump Signs Executive Order to Cut Drug Prices…Benefits for Korean biosimilars? 김새미 2025.04.17 오전 09:11 로딩중..